LONGO, MIRIAM

LONGO, MIRIAM  

Dipartimento di Scienze Cliniche e di Comunità  

Mostra records
Risultati 1 - 20 di 23 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Alcohol or gut microbiota : who is the guilty? 1-set-2019 Meroni M.Longo M.Dongiovanni P. Article (author) -
Genetic and metabolic factors: the perfect combination to treat metabolic associated fatty liver disease 31-ago-2020 Marica MeroniMiriam LongoPaola Dongiovanni Article (author) -
Genetics is of the essence to face NAFLD 30-set-2021 Meroni M.Longo M.Dongiovanni P. + Article (author) -
Genetics, immunity and nutrition boost the switching from nash to hcc 1-gen-2021 Dongiovanni P.Longo M.Fargion S.Fracanzani A. L. + Article (author) -
The KLB rs17618244 gene variant is associated with fibrosing MAFLD by promoting hepatic stellate cell activation 1-mar-2021 Longo M.Valenti L.Paolini E.Fracanzani A. L.Dongiovanni P. + Article (author) -
Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients with Nonalcoholic Fatty Liver Disease 1-gen-2021 Longo M.Lombardi R.Paolini E.Macchi C.Corsini A.Fracanzani A. L.Ruscica M. + Article (author) -
MAFLD in COVID-19 patients: an insidious enemy 1-gen-2020 Dongiovanni P.Meroni M.Longo M.Fracanzani A. L. Article (author) -
MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD 1-lug-2020 Meroni M.Longo M.Fracanzani A. L.Dongiovanni P. Article (author) -
Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes: Mboat7 reduction and hepatic steatosis 1-feb-2020 Meroni M.Dongiovanni P.Longo M.Baselli G.Pelusi S.Fracanzani A. L.Gastaldelli A.Valenti L. + Article (author) -
Mir-101-3p downregulation promotes fibrogenesis by facilitating hepatic stellate cell transdifferentiation during insulin resistance 29-ott-2019 Meroni M.Longo M.Valenti L.Fracanzani A. L.Dongiovanni P. + Article (author) -
MiRNA signature in NAFLD: A turning point for a non-invasive diagnosis 1-dic-2018 Dongiovanni, PaolaMeroni, MaricaLongo, MiriamFargion, SilviaFracanzani, Anna Ludovica Article (author) -
Mitochondrial dynamics and nonalcoholic fatty liver disease (NAFLD): new perspectives for a fairy-tale ending? 1-apr-2021 Longo M.Meroni M.Paolini E.Macchi C.Dongiovanni P. Article (author) -
Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLD 1-ott-2020 Dongiovanni P.Meroni M.Longo M.Valenti L.Miele L.Fargion S.Fracanzani A. L. + Article (author) -
NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease 1-gen-2021 Dongiovanni P.Baselli G.Di Marco V.Longo M.Fracanzani A. L.Valenti L. + Article (author) -
Nutrition and genetics in NAFLD : The perfect binomium 1-apr-2020 Meroni M.Longo M.Dongiovanni P. + Article (author) -
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients 1-giu-2019 Dongiovanni P.Meroni M.Baselli G.Ruscica M.Longo M.Rametta R.Cespiati A.Pelusi S.Ferri N.Ranzani V.Fracanzani A. L.Badiali S.Fargion S.Valenti L. + Article (author) -
Recreating gut-liver axis during NAFLD onset by using a Caco-2/HepG2 co-culture system 22-feb-2022 M. MeroniE. PaoliniM. LongoR. PiciottiS. FargionP. Dongiovanni + Article (author) -
Remodeling of mitochondrial plasticity: The key switch from NAFLD/Nash to HCC 17-apr-2021 Longo M.Paolini E.Dongiovanni P. + Article (author) -
The role of probiotics in nonalcoholic fatty liver disease : A new insight into therapeutic strategies 1-gen-2019 Meroni M.Longo M.Dongiovanni P. Article (author) -
The rs599839 a>g variant disentangles cardiovascular risk and hepatocellular carcinoma in nafld patients 1-gen-2021 Meroni M.Longo M.Paolini E.Miele L.Pisano G.Fracanzani A. L.Dongiovanni P. + Article (author) -